GENE ONLINE|News &
Opinion
Blog

Plaque Psoriasis
GeneOnline’s Weekly News Highlights: Oct 16-Oct 20
2023-10-24
Competing With BMS’s New Psoriasis Drug, Nimbus Gathers $125 Million to Advance Development
2022-09-13
BMS’s Once-Daily Plaque Psoriasis Treatment, Sotyktu, Gains FDA Approval to Rival Otezla
2022-09-12
Study for Janssen Pharmaceuticals’ Severe Plaque Psoriasis Treatment Provides Optimization Insight
2022-09-08
Cosentyx Bags EU Approval for First-Line Treatment of Pediatric Psoriasis
2020-08-05
LATEST
SK Biopharma and Full-Life Sign US$571.5 Million Deal for Innovative Radiopharmaceutical FL-091
2024-07-18
Autoimmune Patients See Breakthrough Response to Allogeneic CD19-Targeted CAR-T Therapy
2024-07-18
Rising Bird Flu Cases in Cattle and Humans Drive Global Efforts in Vaccination, Genetic Monitoring, and Surveillance
2024-07-17
STLI Webinar Series 1: Experts Discuss Regulatory Trends in Regenerative Medicine
2024-07-16
Wistar and Accelerated Biosciences Partner to Develop Novel hTSCs Platform for Immunotherapies
2024-07-15
Accelerated Bio and Pluristyx Generate Clinical-Grade Induced Pluripotent Stem Cells from Reprogrammed Human Trophoblast Stem Cells
2024-07-12
Novo Nordisk and PT Bio Farma Agree to Enhance Insulin Production for Diabetes Patients in Indonesia
2024-07-12
EVENT
Scroll to Top